194 related articles for article (PubMed ID: 8634084)
1. Increased sensitivity to the hepatocarcinogen diethylnitrosamine in transgenic mice carrying the hepatitis B virus X gene.
Slagle BL; Lee TH; Medina D; Finegold MJ; Butel JS
Mol Carcinog; 1996 Apr; 15(4):261-9. PubMed ID: 8634084
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus promotes hepatocarcinogenesis in transgenic mice.
Zheng Y; Chen WL; Louie SG; Yen TS; Ou JH
Hepatology; 2007 Jan; 45(1):16-21. PubMed ID: 17187428
[TBL] [Abstract][Full Text] [Related]
3. Synergy between hepatitis B virus expression and chemical hepatocarcinogens in transgenic mice.
Sell S; Hunt JM; Dunsford HA; Chisari FV
Cancer Res; 1991 Feb; 51(4):1278-85. PubMed ID: 1847661
[TBL] [Abstract][Full Text] [Related]
4. Stable transmission and expression of the hepatitis B virus total genome in hybrid transgenic mice until F10 generation.
Bagis H; Arat S; Mercan HO; Aktoprakligil D; Caner M; Turanli ET; Baysal K; Turgut G; Sekmen S; Cirakoglu B
J Exp Zool A Comp Exp Biol; 2006 May; 305(5):420-7. PubMed ID: 16489557
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B injury, male gender, aflatoxin, and p53 expression each contribute to hepatocarcinogenesis in transgenic mice.
Ghebranious N; Sell S
Hepatology; 1998 Feb; 27(2):383-91. PubMed ID: 9462635
[TBL] [Abstract][Full Text] [Related]
6. High-level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice.
Koike K; Moriya K; Iino S; Yotsuyanagi H; Endo Y; Miyamura T; Kurokawa K
Hepatology; 1994 Apr; 19(4):810-9. PubMed ID: 8138251
[TBL] [Abstract][Full Text] [Related]
7. HBx gene of hepatitis B virus induces liver cancer in transgenic mice.
Kim CM; Koike K; Saito I; Miyamura T; Jay G
Nature; 1991 May; 351(6324):317-20. PubMed ID: 2034275
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of mutant frequencies of chemically induced tumors and normal tissues in lambda/cII transgenic mice.
Mirsalis JC; Shimon JA; Johnson A; Fairchild D; Kanazawa N; Nguyen T; de Boer J; Glickman B; Winegar RA
Environ Mol Mutagen; 2005; 45(1):17-35. PubMed ID: 15605353
[TBL] [Abstract][Full Text] [Related]
9. The hepatitis B virus X gene potentiates c-myc-induced liver oncogenesis in transgenic mice.
Terradillos O; Billet O; Renard CA; Levy R; Molina T; Briand P; Buendia MA
Oncogene; 1997 Jan; 14(4):395-404. PubMed ID: 9053836
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the tumorigenicity of the X gene of hepatitis B virus in a nontransformed hepatocyte cell line and the effects of cotransfection with a murine p53 mutant equivalent to human codon 249.
Oguey D; Dumenco LL; Pierce RH; Fausto N
Hepatology; 1996 Nov; 24(5):1024-33. PubMed ID: 8903370
[TBL] [Abstract][Full Text] [Related]
11. High sensitivity of fatty liver Shionogi (FLS) mice to diethylnitrosamine hepatocarcinogenesis: comparison to C3H and C57 mice.
Iwai S; Murai T; Makino S; Min W; Morimura K; Mori S; Hagihara A; Seki S; Fukushima S
Cancer Lett; 2007 Feb; 246(1-2):115-21. PubMed ID: 16569478
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B virus X protein acts as a tumor promoter in development of diethylnitrosamine-induced preneoplastic lesions.
Madden CR; Finegold MJ; Slagle BL
J Virol; 2001 Apr; 75(8):3851-8. PubMed ID: 11264374
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular carcinoma in WHV/N-myc2 transgenic mice: oncogenic mutations of beta-catenin and synergistic effect of p53 null alleles.
Renard CA; Fourel G; Bralet MP; Degott C; De La Coste A; Perret C; Tiollais P; Buendia MA
Oncogene; 2000 May; 19(22):2678-86. PubMed ID: 10851067
[TBL] [Abstract][Full Text] [Related]
14. [Transgenic mice model of human hepatitis B virus x gene].
Tu Y; Qi Z; Yang P; Pan Y; Yu S; Du M; Li G
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Jun; 22(3):263-5. PubMed ID: 12903473
[TBL] [Abstract][Full Text] [Related]
15. [Observation on experimental liver fibrosis and hepatic carcinogenesis of HBV gene knock-in transgenic mice induced by CCl4/ethanol].
Xu XB; Leng XS; He ZP; Chen L; Zhang HY; Zhang HY; Zhang H; Xiao M; Liu CL; Feng ZQ
Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(12):822-5. PubMed ID: 20450621
[TBL] [Abstract][Full Text] [Related]
16. The five amino acid-deleted isoform of hepatocyte growth factor promotes carcinogenesis in transgenic mice.
Bell A; Chen Q; DeFrances MC; Michalopoulos GK; Zarnegar R
Oncogene; 1999 Jan; 18(4):887-95. PubMed ID: 10023664
[TBL] [Abstract][Full Text] [Related]
17. [Transgenic mouse model for hepatocellular carcinoma in human hepatitis B virus infection].
Koike K
Nihon Rinsho; 1993 Feb; 51(2):536-41. PubMed ID: 8385245
[TBL] [Abstract][Full Text] [Related]
18. Hepatocarcinogenic susceptibility of rasH2 mice to troglitazone in a two-stage hepatocarcinogenesis model.
Jin M; Saekusa Y; Dewa Y; Nishimura J; Matsumoto S; Shibutani M; Hasumi K; Mitsumori K
Arch Toxicol; 2009 Feb; 83(2):173-81. PubMed ID: 18597072
[TBL] [Abstract][Full Text] [Related]
19. Dose-dependent alterations in gene expression in mouse liver induced by diethylnitrosamine and ethylnitrosourea and determined by quantitative real-time PCR.
Watanabe T; Tanaka G; Hamada S; Namiki C; Suzuki T; Nakajima M; Furihata C
Mutat Res; 2009 Feb; 673(1):9-20. PubMed ID: 19100860
[TBL] [Abstract][Full Text] [Related]
20. Increased lung metastasis in transgenic NM23-Null/SV40 mice with hepatocellular carcinoma.
Boissan M; Wendum D; Arnaud-Dabernat S; Munier A; Debray M; Lascu I; Daniel JY; Lacombe ML
J Natl Cancer Inst; 2005 Jun; 97(11):836-45. PubMed ID: 15928304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
